A retrospective evaluation of therapeutic efficacy and safety of chemoradiotherapy in older patients (aged ≥ 75 years) with limited-disease small cell lung cancer: Insights from two institutions: Chemoradiotherapy in older patients with limited-disease small cell lung cancer. Radiol Oncol [Internet]. 2024 Sep. 9 [cited 2026 Jul. 30];58(3):432-43. Available from: https://www.ojstest.computing.si/index.php/ro/article/view/4269